Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the treatment of 131 cases with ozone therapy

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 12, 2012, Pages 1741-1747

  Agrillo, A ^a   Filiaci, F ^a   Ramieri, V ^a   Riccardi, E ^a   Quarato, D ^a   Rinna, C ^a   Gennaro, P ^a   Cascino, F ^a   Mitro, V ^a   Ungari, C ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Biphosphonates; BRONJ treatment; Ozonetherapy; Pamidronate; Zoledronic acid

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ASCORBIC ACID; BETA LACTAM; BISPHOSPHONIC ACID DERIVATIVE; CHLORHEXIDINE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BISPHOSPHONATE RELATED OSTEONECROSIS OF THE JAW; BREAST CANCER; CLINICAL PROTOCOL; DRUG INDUCED DISEASE; FEMALE; HUMAN; JAW OSTEONECROSIS; KIDNEY CANCER; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; MULTIPLE MYELOMA; OSTEOPOROSIS; OUTCOME ASSESSMENT; OZONE THERAPY; PRACTICE GUIDELINE; PROSTATE CANCER; RETROSPECTIVE STUDY; SYMPTOM; THYROID CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; FEMALE; HUMANS; MALE; MIDDLE AGED; OZONE; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 84870901837     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. WANG J, GOODGER NM, POGREL MA. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 2003; 61:1104-1107.
2. OLSON KB, HELUE CM, PIENTA KJ. Osteonecrosis of the jaw in patient with hormone refractory prostate cancer treated with Zolendronic acid. Urology 2005;66:658-661.
3. RUGGIERO SL, MEHROTRA B, ROSENBERG TJ. Osteonecrosis of the jaws associated with the use of biphosphonates: a review of 63 cases. J Oral Maxillofacial Surg 2004; 62: 527-534.
4. FOURNIER P, BOISSIER S, FlLLEUR S, GUGLIELMI J, CABON F, COLOMBEL M, CLÉZARDIN P. Biphosphonatesinhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 2002; 15:6538-6544.
5. AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS. Position Paper on Bisphosphonate-Realted Osteonecrosis of the Jaws. J Oral Maxillofac Surg 2007; 65: 369-376.
6. BAMIAS A, KASTRITIS E, BAMIA C. Osteonecrosis of the jaw in cancer after treatment with biphosphonates:incidence and risk factors. J Clin One 2005; 23: 8580-8587.
7. AGRILLO A, UNGARI C, FILIACI F, PRIORE P IANNETTI G. Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis. J Craniofac Surg 2007; 18: 1071-1075.
8. AGRILLO A, SASSANO P RINNA C, PRIORE P IANNETTI G. Ozone therapy in extractive surgery on patients treated with bisphosphonates. J Craniofac Surg 2007; 18: 1068-1070.
9. MARX RE. Pamidronate aredia and zolendronate zometa induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofacial Surg 2003; 61: 1115-1117.
10. GREENBERG MS. Intravenous bisphosphonates and osteonecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98: 259-260.
11. LEON A, ASSAEL J. Oral biphosphonates as a cause of biphosphonate-related osteonecrosis of the jaws: clinical findings assessment of risks, and preventive strategies. J Oral Maxillofac Surg 2009; 67(1 Suppl): 35-43.
12. VIALE PH, LIN H. Exposed bone in Oral Cavities. Clin J Oncol Nurs 2005; 9: 355-357.
13. RUGGIERO SL, FANTASIA J, CARLSON E. Bisphosphonate-related osteonecrosis of the jaws: background and guide lines for diagnosis, staging and management. Oral Surg Oral Med Oral Path Oral Rad Endodontol 2006; 102: 433-441.
14. UPDATE AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS. Position paper on bisphosphonaterealted osteonecrosis of the jaws. J Oral Maxillofac Surg 2009; 67(5 Suppl): 2-12.
15. KHOSLA S, BURR D, CAULEY J, DEMPSTER DW, EBELING PR, FELSENBERG D, GAGEL RF, GILSANZ V, GUISE T, KOKA S, MCCAULEY LK, MCGOWAN J, MCKEE MD, MOHLA S, PENDRYS DG, RAISZ LG, RUGGIERO SL, SHAFER DM, SHUM L, SILVERMAN SL, VAN POZNAK CH, WATTS N, WOO SB, SHANE E. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007; 22: 1479-1491.
16. BEDOGNI A, Fusco V, AGRILLO A, CAMPISI G. Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ). Oral Dis 2012; 18: 621-623.
17. CAMPISI G, LO RUSSO L, AGRILLO A, VESCOVI P Fusco V, BEDOGNI A. BRONJ expert panel recommendation of the Italian Societies for Maxillofacial Surgery (SICMF) and Oral Pathology and Medicine (SIPMO) on Bisphosphonate-Related Osteonecrosis of the Jaws: risk assessment, preventive strategies and dental management. Italian J Maxillofacial Surg 2011; 22: 103-124.
18. FREIBERGER JJ. The utility of hyperbaric oxygen in the treatment of biphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2009; 67(5 Suppl): 96-106.
19. AGRILLO A, NASTRO SINISCALCHI E, FACCHINI A, FILIACI F, UNGARI C. Osteonecrosis of the jaws in patients assuming bisphosphonates and sunitinib: two case reports. Eur Rev Med Pharmacol Sei 2012; 16: 952-957.
20. DAYAS A, BOUGHTON BJ, DAS BC. Ozone killing action against bacterial and fungal species; mcrobiological testing of a domestic ozone generator. J Clin Pathol 1983; 36: 1102-1104.
21. MULLER P GUGGENHEIM B, SHMIDLIN R Efficacy of gasiform ozone and photodynamic therapy on a multispecies oral biofilm in vitro. Eur J Oral Sei 2007; 115: 77-80.
22. Bocci V. Ozone as Janus. Mediators lnflamm 2004; 13: 3-11.
23. WOLFF HH. Die behaundlung peripherer durchblutungsstorungen mit ozon. Erfahr hk 1974; 23: 181-184.
24. NOGALES CG, FERRARI PH, KANTOROVICH EO, LAGEMARQUES JL. Ozone therapy in medicine and dentistry. J Contemp Dent Pract 2008; 9: 75-84.
25. MORREY BF, DUNN JM, HEIMBACH RD, DAVIS J. Hyperbaric oxygen and chronic osteomyelitis. Clin Orthop Relat Res 1979; 144: 121-127.
26. AZARPAZHOOH A, LiMEBACK H. The application of ozone in dentistry: a systematic review of literature. J Dent 2008; 36: 104-116.
27. STEINHART H, SCHULZ S, MUTTERS R. Evaluation of ozonated oxygen in an experimental animal model of osteomyelitis as a further treatment option for skull-base osteomyelitis. Eur Arch Otorhinolaryngol 1999; 256: 153-157.